Table 2.

Crude survival (%) after selected cancers diagnosed after initiation of colonoscopy surveillance and before age 65 years for path_MLH1, path_MSH2, and path_MSH6 carriers

Cancer	Organ	n	5-year survival (%)	95% CI (%)	10-year survival (%)	95% CI (%)
Colorectala
	Colon	274	95	[90–97]	88	[81–93]
	Rectal and sigmoid	62	75	[61–85]	70	[52–82]
Gynecologicala
	Endometrium	136	89	[82–94]	89	[82–94]
	Ovarian	41	84	[68–93]	84	[68–93]
Urinary tracta
	Ureter and kidney	53	86	[71–94]	67	[41–84]
	Urinary bladder	31	81	[60–92]	68	[42–84]
Others
	Prostatea	26	96	[75–99]	70	[37–88]
	Breasta	51	92	[78–98]	82	[64–92]
	Stomach	15	72	[47–86]	72	[47–86]
	Small bowel	24	81	[59–92]	71	[41–87]
	Biliary tract	8	42	[15–67]	42	[15–67]
	Pancreas	6	29	[6–58]	29	[6–58]
	Brain	2	15	[2–37]	15	[2–37]

CI confidence interval.

^aRight censored for International Classification of Diseases version 9 (ICD-9) diagnostic system 151, 152, 156, or 157.